chlamydia, screening

profilegbardowell
qualityimprovementreferenceswk2.docx

Please use these 3 articles and the suggested articles can be substituted

Salomon, S. G., Torrone, E., Nakatsukasa-Ono, W., & Fine, D. N. (2017). Missed Opportunities for Chlamydia Screening in Title X Family Planning Clinics. Sexually Transmitted Diseases44(9), 519–523. https://doi.org/10.1097/OLQ.0000000000000641

Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Stevermer, J., Tseng, C.-W., & Wong, J. B. (2021). Screening for Chlamydia and Gonorrhea: US https://doi.org/10.1001/jama.2021.14081

Phillips, J. A. (2019). Chlamydia Infections. Workplace Health & Safety, 67(7), 375–376. https://doi.org/10.1177/2165079919853590

Suggested articles

Territo, H., & Burstein, G. (2021). Chlamydia Screening Post COVID-19. Contemporary OB/GYN66(7), 1–4.

Freeman, J., Pettit, J., & Howe, C. (2020). Chlamydia test-of-cure in pregnancy. Canadian Family Physician Medecin de Famille Canadien66(6), 427–428.